Literature DB >> 14688825

The assessment of LIF in uterine flushing--a possible new diagnostic tool in states of impaired fertility.

Mateusz Mikołajczyk1, Jana Skrzypczak, Krzysztof Szymanowski, Przemysław Wirstlein.   

Abstract

The objective of this study was to assess the LIF (leukemia inhibitory factor) concentration in uterine flushing and serum (ELISA) of women with proven fertility, infertile women and women with recurrent miscarriage. In addition, progesterone level was determined in serum. A decreased production of LIF in the uterine microenvironment was found in states of impaired fertility. With a cut-off point of 8.23 pg/ml for LIF level in uterine flushings we have achieved 86.7% sensitivity and 100% specificity in detection of women with idiopathic infertility compared to fertile controls. No correlation between LIF in serum and uterine flushing was demonstrated, rendering LIF measurements in serum useless for diagnosis of impaired infertility. We conclude that LIF measurement in uterine flushing could be a useful diagnostic tool to predict unsuccessful implantation.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14688825

Source DB:  PubMed          Journal:  Reprod Biol        ISSN： 1642-431X            Impact factor:   2.376


  11 in total

Review 1.  Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion.

Authors:  Ming-Qing Li; Li-Ping Jin
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

Review 2.  Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium.

Authors:  M Králícková; P Síma; Z Rokyta
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study.

Authors:  Laura D Almquist; Creighton E Likes; Benjamin Stone; Kaitlin R Brown; Ricardo Savaris; David A Forstein; Paul B Miller; Bruce A Lessey
Journal:  Fertil Steril       Date:  2017-11-07       Impact factor: 7.329

Review 4.  Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics.

Authors:  L Aghajanova; A E Hamilton; L C Giudice
Journal:  Semin Cell Dev Biol       Date:  2007-10-22       Impact factor: 7.727

5.  Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility.

Authors:  Jason M Franasiak; Kristin J Holoch; Lingwen Yuan; David P Schammel; Steven L Young; Bruce A Lessey
Journal:  Fertil Steril       Date:  2014-03-29       Impact factor: 7.329

6.  Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor.

Authors:  Jemma Evans; Rob D Catalano; Pamela Brown; Rob Sherwin; Hilary O D Critchley; Asgerally T Fazleabas; Henry N Jabbour
Journal:  FASEB J       Date:  2009-03-02       Impact factor: 5.191

7.  Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity.

Authors:  Noriko Yoshii; Toshio Hamatani; Noboru Inagaki; Takeshi Hosaka; Osamu Inoue; Mitsutoshi Yamada; Rei Machiya; Yasunori Yoshimura; Yasushi Odawara
Journal:  Reprod Biol Endocrinol       Date:  2013-05-11       Impact factor: 5.211

8.  Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study.

Authors:  Joanne Hempstock; Tereza Cindrova-Davies; Eric Jauniaux; Graham J Burton
Journal:  Reprod Biol Endocrinol       Date:  2004-07-20       Impact factor: 5.211

9.  Impact of soluble HLA-G levels and endometrial NK cells in uterine flushing samples from primary and secondary unexplained infertile women.

Authors:  Roberta Rizzo; Giuseppe Lo Monte; Daria Bortolotti; Angela Graziano; Valentina Gentili; Dario Di Luca; Roberto Marci
Journal:  Int J Mol Sci       Date:  2015-03-10       Impact factor: 5.923

10.  Evaluation of Endometrial Receptivity by Measuring HOXA-10, HOXA-11, and Leukemia Inhibitory Factor Expression in Patients with Polycystic Ovary Syndrome.

Authors:  Mustafa Kara; Seda Sabah Ozcan; Turhan Aran; Ozlem Kara; Neziha Yilmaz
Journal:  Gynecol Minim Invasive Ther       Date:  2019-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.